Document is current

Any future updates will be listed below

263 ASD141, an innate checkpoint inhibitor, modulates tumor associated myeloid cells through CD11b and enhances current immune checkpoint blockade in preclinical model

Crossref DOI link: https://doi.org/10.1136/jitc-2021-SITC2021.263

Published Online: 2021-11-10

Published Print: 2021-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark